US4643988A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Amphipathic peptides
Assignee: RESEARCH Corp A NY CORP
•
Filing: 1984-05-15
•
Granted: 1987-02-17
•
Expires: 2004-05-15
Abstract
Abstract The present invention relates to peptides of the formula A.sub.1 -B.sub.1 -B.sub.2 -C.sub.1 -D-B.sub.3 -B.sub.4 -A.sub.2 -C.sub.2 -B 5 -B 6 -A 3 -C 3 -B 7 -C 4 -A 4 -B 8 -B 9 wherein: A 1 , A 2 , A 3 and A 4 are independently aspartic acid or glutamic acid, or homologues or analogues thereof; B 1 , B 2 , B 3 , B 4 , B 5 , B 6 , B 7 , B 8 and B 9 are independently tryptophan, phenylalanine, leucine, alanine, tyrosine, isoleucine, valine or α-naphtylalanine, or homologues or analogues thereof; C 1 , C 2 , C 3 , and C 4 are independently lysine or arginine, or homologues or analogues thereof, and D is serine, threonine, alanine, glycine, or histidine; provided that, when A 1 and A 2 are aspartic acid, A 3 and A 4 are glutamic acid, B 2 and B 7 are leucine, B 3 and B 9 are phenylalanine, B 4 is tyrosine, B 5 is valine, and C 1 , C 2 , C 3 and C 4 are lysine, and B 6 , B 8 and D are alanine, B 1 is not tryptophan. These peptides are useful in the treatment and prevention of atherosclerosis.
Inventors
- 👤 Jere P. Segrest
- 👤 Gattadahalli M. Anantharamaiah
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 11:24
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/775; A; A61; A61P; A61P3/00; A61P3/06; A61K; A61K38/00
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
14 words
A peptide capable of forming an amphipathic helix, said peptide having the sequence Asp-Trp-αNal-Lys-Ala-Phe-αNal-Asp-Lys-αNal-Ala-Glu-Lys-.alpha.Nal-Lys-Glu-Ala-Phe.
Claim 2
Dependent Claim
14 words
A peptide capable of forming an amphipathic helix, said peptide having the sequence Asp-Trp-αNal-Lys-Ala-Phe-αNal-Asp-Lys-αNal-Ala-Glu-Lys-.alpha.Nal-Lys-Glu-Ala-Phe.
Claim 3
Dependent Claim
21 words
A synthetic high density lipoprotein which comprises a peptide capable of forming an amphipathic helix, said peptide having the sequence: Asp-Trp-αNal-Lys-Ala-Phe-αNal-Asp-Lys-αNal-Ala-Glu-Lys-.alpha.Nal-Lys-Glu-Ala-Phe.
Claim 4
Dependent Claim
21 words
A synthetic high density lipoprotein which comprises a peptide capable of forming an amphipathic helix, said peptide having the sequence: Asp-Trp-αNal-Lys-Ala-Phe-αNal-Asp-Lys-αNal-Ala-Glu-Lys-.alpha.Nal-Lys-Glu-Ala-Phe.
Claim 5
Dependent Claim
16 words
The lipoprotein of claim 2 wherein the phospholipid is phosphatidylcholine, dimyristyl phosphatidyl chlorine or dipalmitoyl phosphatidylcholine.
Claim 6
Dependent Claim
26 words
A therapeutic composition useful in the treatment and prevention of atherosclerosis which comprises the synthetic lipoprotein of claim 2, in combination with a pharmaceutically acceptable carrier.
Claim 7
Independent Claim
37 words
A method of treatment or prevention of atherosclerosis which comprises administering to a host in need of such treatment an effective amount of a syntheic lipoprotein comprising a peptide having the sequence: Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Gly-Ala-Phe; bound to a phospholipid.
Claim 8
Independent Claim
37 words
A method of treatment or prevention of atherosclerosis which comprises administering to a host in need of such treatment an effective amount of a syntheic lipoprotein comprising a peptide having the sequence: Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Gly-Ala-Phe; bound to a phospholipid.
Claim 9
Independent Claim
37 words
A method of treatment or prevention of atherosclerosis which comprises administering to a host in need of such treatment an effective amount of a synthetic lipoprotein comprising a peptide having the sequence: Asp-Trp-αNal-Lys-Ala-Phe-αNal-Asp-Lys-αNal-Ala-Glu-Lys-.alpha.Nal-Lys-Glu-Ala-Phe; bound to a phospholipid.
Claim 10
Independent Claim
37 words
A method of treatment or prevention of atherosclerosis which comprises administering to a host in need of such treatment an effective amount of a synthetic lipoprotein comprising a peptide having the sequence: Asp-Trp-αNal-Lys-Ala-Phe-αNal-Asp-Lys-αNal-Ala-Glu-Lys-.alpha.Nal-Lys-Glu-Ala-Phe; bound to a phospholipid.
Claim 11
Independent Claim
37 words
A method of treatment or prevention of atherosclerosis which comprises administering to a host in need of such treatment an effect amount of a synthetic lipoprotein comprising a peptide having the sequence: Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Gly-Ala-Phe-Pro-Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Gly-Ala-Phe; bound to a phospholipid.
Claim 12
Independent Claim
37 words
A method of treatment or prevention of atherosclerosis which comprises administering to a host in need of such treatment an effect amount of a synthetic lipoprotein comprising a peptide having the sequence: Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Gly-Ala-Phe-Pro-Asp-Trp-Leu-Lys-Ala-Phe-Tyr-Asp-Lys-Val-Ala-Glu-Lys-Leu-Lys-Gly-Ala-Phe; bound to a phospholipid.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-02-16 | 1990-08-18 | 1991-02-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-02-16 | 1994-08-18 | 1995-02-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-02-16 | 1998-08-18 | 1999-02-17 | $7700.00 | Window Closed / Lapsed |